Therapeutic potential of benzothiazoles: a patent review (2010-2014)

被引：112
作者：
Kamal, Ahmed [1 ]
Syed, Mohammed Ali Hussaini [1 ]
Mohammed, Shaheer Malik [1 ]
机构：
[1] CSIR, Indian Inst Chem Technol Med Chem & Pharmacol, Hyderabad 500007, Andhra Pradesh, India
来源：
EXPERT OPINION ON THERAPEUTIC PATENTS | 2015年 / 25卷 / 03期
关键词：
anticancer; antidiabetic; anti-inflammatory; antimicrobials; benzothiazole; CANCER CELL-LINES; ANTITUMOR BENZOTHIAZOLES; ANTICONVULSANT ACTIVITY; KINASE INHIBITORS; IN-VITRO; 2-AMINOBENZOTHIAZOLES; CHEMISTRY; RILUZOLE; SCAFFOLD; VIVO;
D O I：
10.1517/13543776.2014.999764
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Introduction: Benzothiazole is a versatile fused heterocyclic scaffold with extensive pharmaceutical applications. Several benzothiazole derivatives possess broad spectrum of antimicrobial, analgesic, anti-inflammatory, antidiabetic activities and so on, and the structurally simple 2-arylbenzothiazoles are potential antitumor agents. Some of the compounds containing benzothiazole ring system are in clinical usage for the treatment of various diseases/disorders. Areas covered: In the present review, the authors summarize inventions carried out towards the development of benzothiazole-based chemotherapeutic agents. It provides an overview of the patents filed during 2010 - 2014 pertaining to the anticancer, antimicrobial, anti-inflammatory and other biological activities of benzothiazole derivatives. Expert opinion: Several molecules containing benzothiazole skeleton are agents of choice for the treatment of various human diseases/disorders. Its versatile character of being capable of serving as ligand to various biomolecules attracted the interest of medicinal chemists for the development of therapies for respective ailments, especially, the 2-arylbenzothiazole moiety which is under development for the treatment of cancer. This signifies the increasing importance of benzothiazole nucleus in the area of drug discovery. Its structural simplicity and ease of synthesis provides scope for the development of chemical libraries that could serve in the discovery of new chemical entities progressing towards the market.
引用
收藏
页码：335 / 349
页数：15
相关论文
共 90 条
[1]   Design, synthesis and in vitro antimicrobial evaluation of novel Imidazo[1,2-a]pyridine and imidazo[2,1-b][1,3]benzothiazole motifs [J].
Al-Tel, Taleb H. ;
Al-Qawasmeh, Raed A. ;
Zaarour, Rania .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (05) :1874-1881
[2]  
Alder CM, 2011, Preparation of 2-[2-(benzo-or pyrido-) thiazolylamino]-6-aminopyridine derivatives useful in the treatment of respiratory, allergic or inflammatory diseases, Patent No. [WO110575, 110575]
[3]   Synthesis, anticonvulsant activity and 3D-QSAR study of some prop-2-eneamido and 1-acetyl-pyrazolin derivatives of aminobenzothiazole [J].
Amnerkar, Nikhil D. ;
Bhusari, Kishore P. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (01) :149-159
[4]  
Apuy JL, 2010, Preparation of imidazobenzothiazoles as modulators of protein kinase, Patent No. [WO054058, 054058]
[5]  
Aronov A, 2010, Preparation of benzothiazole derivatives for use as PI3K inhibitors and useful in the treatment of autoimmune diseases, Patent No. [WO135014, 135014]
[6]  
Bacque E, 2010, Preparation of imidazo[1,2-a] pyrimidine derivatives as c-Met inhibitors and their pharmaceutical compositions, Patent No. [WO007318, 007318]
[7]  
Bayer CropScience AG, 2011, Substituted benzoxazoles and benzothiazoles as fungicides and their preparation and use for fighting harmful microorganisms, Patent No. [EP2277870, 2277870]
[8]  
Bayer CropScience AG, 2011, Cycloalkylamidobenzoxazoles and benzothiazoles as fungicides and their preparation and use for fighting harmful microorganisms in plants, Patent No. [EP2277869, 2277869]
[9]  
Bellenie BR, 2011, Piperidine derivatives as microsomal prostaglandin E syntase-1 inhibitors and their preparation, pharmaceutical compositions and use in the treatment of diseases, Patent No. [WO131975, 131975]
[10]  
Bhagwat SS, 2011, Preparation of imidazo [2,1-b][1,3] benzothiazole derivatives for treatment of proliferative diseases, Patent No. [WO056764, 056764]
123456789